{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:14:56Z","timestamp":1776356096853,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T00:00:00Z","timestamp":1302825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11940-011-0131-z","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T07:26:17Z","timestamp":1302765977000},"page":"355-370","source":"Crossref","is-referenced-by-count":56,"title":["Treatment Options in Juvenile Myoclonic Epilepsy"],"prefix":"10.1007","volume":"13","author":[{"given":"Laura","family":"Mantoan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"131_CR1","volume-title":"The epilepsies bilateral seizures, syndromes and management","author":"C Panayiotopoulos","year":"2005","unstructured":"Panayiotopoulos C. The epilepsies bilateral seizures, syndromes and management. Oxfordshire: Bladon Medical Publishing; 2005. ISBN-10: 1-904218-34-2."},{"issue":"9566","key":"131_CR2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016\u201326.","journal-title":"Lancet"},{"issue":"6","key":"131_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","volume":"10","author":"S Calleja","year":"2001","unstructured":"Calleja S, Salas-Puig J, Ribacoba R, Lahoz CH. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure. 2001;10(6):424\u20137. doi: 10.1053\/seiz.2000.0530 .","journal-title":"Seizure"},{"key":"131_CR4","first-page":"75","volume":"75","author":"A Nicolson","year":"2004","unstructured":"Nicolson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry. 2004;75:75\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"131_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.56.4.519","volume":"56","author":"TS Walczak","year":"2001","unstructured":"Walczak TS, Leppik IE, D\u2019Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology. 2001;56(4):519\u201325.","journal-title":"Neurology"},{"issue":"5","key":"131_CR6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","volume":"342","author":"P Kwan","year":"2000","unstructured":"Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314\u20139. doi: 10.1056\/NEJM200002033420503 .","journal-title":"N Engl J Med"},{"issue":"2","key":"131_CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"J Morrow","year":"2006","unstructured":"Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77(2):193\u20138. doi: 10.1136\/jnnp.2005.074203 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"131_CR8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jnnp.57.4.503","volume":"57","author":"C Knott","year":"1994","unstructured":"Knott C, Panayiotopoulos CP. Carbamazepine in the treatment of generalised tonic clonic seizures in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 1994;57(4):503.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"131_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/1059-1311(92)90039-4","volume":"1","author":"MP Canevini","year":"1992","unstructured":"Canevini MP, Mai R, Marco CD, et al. Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients. Seizure. 1992;1(4):291\u20138.","journal-title":"Seizure"},{"issue":"4","key":"131_CR10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","volume":"43","author":"PN Patsalos","year":"2002","unstructured":"Patsalos PN, Fr\u00f6scher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43(4):365\u201385.","journal-title":"Epilepsia"},{"issue":"10","key":"131_CR11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/09513590802288259","volume":"24","author":"L Bilo","year":"2008","unstructured":"Bilo L, Meo R. Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol. 2008;24(10):562\u201370. doi: 10.1080\/09513590802288259 .","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"131_CR12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","volume":"64","author":"DF Wyszynski","year":"2005","unstructured":"Wyszynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64(6):961\u20135.","journal-title":"Neurology"},{"issue":"3","key":"131_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","volume":"19","author":"JH DiLiberti","year":"1984","unstructured":"DiLiberti JH, Farndon PA, Dennis NR, Curry CJ. The fetal valproate syndrome. Am J Med Genet. 1984;19(3):473\u201381. doi: 10.1002\/ajmg.1320190308 .","journal-title":"Am J Med Genet"},{"issue":"2","key":"131_CR14","doi-asserted-by":"crossref","first-page":"F90","DOI":"10.1136\/adc.2004.067421","volume":"91","author":"U Kini","year":"2006","unstructured":"Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J. Liverpool and Manchester Neurodevelopmental Study Group: dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed. 2006;91(2):F90\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"131_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1535-7511.2008.00273.x","volume":"8","author":"KJ Meador","year":"2008","unstructured":"Meador KJ. Effects of in utero antiepileptic drug exposure. Epilepsy Curr. 2008;8(6):143\u20137. doi: 10.1111\/j.1535-7511.2008.00273.x .","journal-title":"Epilepsy Curr"},{"issue":"18","key":"131_CR16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","volume":"69","author":"SF Berkovic","year":"2007","unstructured":"Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Levetiracetam N01057 Study Group: placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology. 2007;69(18):1751\u201360.","journal-title":"Neurology"},{"issue":"8","key":"131_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","volume":"70","author":"S Noachtar","year":"2008","unstructured":"Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology. 2008;70(8):607\u201316.","journal-title":"Neurology"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eplepsyres.2009.02.016","volume":"85","author":"WE Rosenfeld","year":"2009","unstructured":"Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res. 2009;85:72\u201380. doi: 10.1016\/j.eplepsyres.2009.02.016 .","journal-title":"Epilepsy Res"},{"issue":"3","key":"131_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(96)00031-9","volume":"25","author":"DG Kasteleijn-Nolst Trenit\u00e9","year":"1996","unstructured":"Kasteleijn-Nolst Trenit\u00e9 DG, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res. 1996;25(3):225\u201330.","journal-title":"Epilepsy Res"},{"issue":"4","key":"131_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pediatrneurol.2010.05.008","volume":"43","author":"MG Dahlin","year":"2010","unstructured":"Dahlin MG, Wide K, Ohman I. Age and comedications influence levetiracetam pharmacokinetics in children. Pediatr Neurol. 2010;43(4):231\u20135. doi: 10.1016\/j.pediatrneurol.2010.05.008 .","journal-title":"Pediatr Neurol"},{"issue":"10","key":"131_CR21","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000244491.48937.55","volume":"67","author":"S Hunt","year":"2006","unstructured":"Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2006;67(10):1876\u20139. doi: 10.1212\/01.wnl.0000244491.48937.55 .","journal-title":"Neurology"},{"key":"131_CR22","doi-asserted-by":"crossref","unstructured":"Kennedy F, Morrow S, Hunt S, et al. PATH39 Malformation risks of antiepileptic drugs in pregnancy: an update from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2010;81:e18.","DOI":"10.1136\/jnnp.2010.226340.7"},{"issue":"12","key":"131_CR23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1528-1157.1998.tb01332.x","volume":"39","author":"RG Beran","year":"1998","unstructured":"Beran RG, Berkovic SF, Dunagan FM, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia. 1998;39(12):1329\u201333.","journal-title":"Epilepsia"},{"issue":"7","key":"131_CR24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","volume":"40","author":"LM Frank","year":"1999","unstructured":"Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40(7):973\u20139.","journal-title":"Epilepsia"},{"issue":"11","key":"131_CR25","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.55.11.1757","volume":"55","author":"A Biraben","year":"2000","unstructured":"Biraben A, Allain H, Scarabin JM, Sch\u00fcck S, Edan G. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology. 2000;55(11):1758.","journal-title":"Neurology"},{"issue":"3","key":"131_CR26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","volume":"26","author":"MJ Brodie","year":"1997","unstructured":"Brodie MJ, Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res. 1997;26(3):423\u201332.","journal-title":"Epilepsy Res"},{"issue":"6 Suppl 3","key":"131_CR27","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1212\/WNL.66.66_suppl_3.S37","volume":"66","author":"ML Zupanc","year":"2006","unstructured":"Zupanc ML. Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy. Neurology. 2006;66(6 Suppl 3):S37\u201345.","journal-title":"Neurology"},{"issue":"4","key":"131_CR28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/01.WNL.0000076485.09353.7A","volume":"61","author":"A Sabers","year":"2003","unstructured":"Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology. 2003;61(4):570\u20131.","journal-title":"Neurology"},{"issue":"17","key":"131_CR29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.0b013e3181bd8295","volume":"73","author":"I Wegner","year":"2009","unstructured":"Wegner I, Edelbroek PM, Bulk S, Lindhout D. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives. Neurology. 2009;73(17):1388\u201393. doi: 10.1212\/WNL.0b013e3181bd8295 .","journal-title":"Neurology"},{"issue":"22 Pt 2","key":"131_CR30","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","volume":"70","author":"LB Holmes","year":"2008","unstructured":"Holmes LB, Baldwin EJ, Smith CR, et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology. 2008;70(22 Pt 2):2152\u20138. doi: 10.1212\/01.wnl.0000304343.45104.d6 .","journal-title":"Neurology"},{"issue":"10","key":"131_CR31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1528-1157.2002.45901.x","volume":"43","author":"P Tennis","year":"2002","unstructured":"Tennis P, Eldridge RR. International Lamotrigine Pregnancy Registry Scientific Advisory Committee: preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia. 2002;43(10):1161\u20137.","journal-title":"Epilepsia"},{"issue":"7","key":"131_CR32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.52.7.1330","volume":"52","author":"V Biton","year":"1999","unstructured":"Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999;52(7):1330\u20137.","journal-title":"Neurology"},{"issue":"11","key":"131_CR33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archneur.62.11.1705","volume":"62","author":"V Biton","year":"2005","unstructured":"Biton V, Bourgeois BFD. YTC\/YTCE Study Investigators: topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol. 2005;62(11):1705\u20138.","journal-title":"Arch Neurol"},{"issue":"3","key":"131_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","volume":"107","author":"MD Privitera","year":"2003","unstructured":"Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand. 2003;107(3):165\u201375.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"131_CR35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","volume":"71","author":"S Hunt","year":"2008","unstructured":"Hunt S, Russell A, Smithson WH, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2008;71(4):272\u20136.","journal-title":"Neurology"},{"key":"131_CR36","first-page":"408","volume":"88","author":"S Hern\u00e1ndez-D\u00edaz","year":"2010","unstructured":"Hern\u00e1ndez-D\u00edaz S, Mittendorf R, Holmes LB. Comparative safety of topiramate during pregnancy [abstract]. Birth Defects Research Part A. 2010;88:408.","journal-title":"Birth Defects Research Part A"},{"issue":"5","key":"131_CR37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pediatrneurol.2005.10.007","volume":"34","author":"SV Kothare","year":"2006","unstructured":"Kothare SV, Kaleyias J, Mostofi N, et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol. 2006;34(5):351\u20134. doi: 10.1016\/j.pediatrneurol.2005.10.007 .","journal-title":"Pediatr Neurol"},{"key":"131_CR38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1684\/epd.2009.0239","volume":"11","author":"A Marinas","year":"2009","unstructured":"Marinas A, Villanueva V, Gir\u00e1ldez BG, et al. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy. Epileptic Disord. 2009;11:61\u20136. doi: 10.1684\/epd.2009.0239 .","journal-title":"Epileptic Disord"},{"issue":"12","key":"131_CR39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1528-1157.1996.tb00560.x","volume":"37","author":"T Kondo","year":"1996","unstructured":"Kondo T, Kaneko S, Amano Y, Egawa I. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia. 1996;37(12):1242\u20134.","journal-title":"Epilepsia"},{"issue":"5","key":"131_CR40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1528-1157.1989.tb05479.x","volume":"30","author":"T Obeid","year":"1989","unstructured":"Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia. 1989;30(5):603\u20136.","journal-title":"Epilepsia"},{"key":"131_CR41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0404.1987.tb03545.x","volume":"76","author":"H Naito","year":"1987","unstructured":"Naito H, Wachi M, Nishida M. Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics. Acta Neurol Scand. 1987;76:58\u201363.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"131_CR42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneur.1976.00500050008002","volume":"33","author":"B Mikkelsen","year":"1976","unstructured":"Mikkelsen B, Birket-Smith E, Bradt S, et al. Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch Neurol. 1976;33(5):322\u20135.","journal-title":"Arch Neurol"},{"issue":"12","key":"131_CR43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.47.12.1279","volume":"47","author":"M Feely","year":"1984","unstructured":"Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry. 1984;47(12):1279\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"131_CR44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bdra.20051","volume":"70","author":"AE Lin","year":"2004","unstructured":"Lin AE, Peller AJ, Westgate MN, et al. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res A Clin Mol Teratol. 2004;70(8):534\u20136. doi: 10.1002\/bdra.20051 .","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"131_CR45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0404.2007.00848.x","volume":"187","author":"H Kostov","year":"2007","unstructured":"Kostov H, Larsson PG, R\u00f8ste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl. 2007;187:55\u20138. doi: 10.1111\/j.1600-0404.2007.00848.x .","journal-title":"Acta Neurol Scand Suppl"},{"key":"131_CR46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1528-1157.2002.40100.x","volume":"43","author":"P Boon","year":"2002","unstructured":"Boon P, D\u2019Hav\u00e9 M, Walleghem PV, et al. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia. 2002;43:96\u2013102.","journal-title":"Epilepsia"},{"key":"131_CR47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1528-1167.2006.00377.x","volume":"47","author":"M Nei","year":"2006","unstructured":"Nei M, O\u2019Connor M, Liporace J, Sperling MR. Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation. Epilepsia. 2006;47:115\u201322. doi: 10.1111\/j.1528-1167.2006.00377.x .","journal-title":"Epilepsia"},{"issue":"5","key":"131_CR48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1528-1167.2010.02536.x","volume":"51","author":"R Fisher","year":"2010","unstructured":"Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899\u2013908. doi: 10.1111\/j.1528-1167.2010.02536.x .","journal-title":"Epilepsia"},{"issue":"4","key":"131_CR49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1684\/epd.2007.0144","volume":"9","author":"JW Wheless","year":"2007","unstructured":"Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007;9(4):353\u2013412. doi: 10.1684\/epd.2007.0144 .","journal-title":"Epileptic Disord"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0131-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-011-0131-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0131-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:01:46Z","timestamp":1712376106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-011-0131-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0131-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}